Table 1.
Type ofcargo |
Sorted cargo |
Related molecules |
Sorting mechanism |
Role of exosomes/Related disease/miRNA Binding Motifs |
Extraction Methods for sEVs |
Ref. |
|
protein | Nedd4 familyproteins | Ndfip1 | ubiquitination-like | Ndfip1 interacts with Nedd4 family proteins | Remove the harmful substances to improve neuronal survival in case of brain injury. | 1 | [20, 30] |
α-synuclein | SUMO | SUMOylation of proteins via interacting with phosphoinositols and some subunits of ESCRT complex such as ALIX, VPS4. | Helpful for analyzing the Parkinson’s Disease pathogenesis at molecular level. | 1 and 2 | [25,26] | ||
RasG12V | UBL3 | UBL modify proteins through the C-terminal cysteine residue disulfide bond. | Sorting of RasG12V could improve the activation of Ras signaling. | 1 | [27] | ||
eGFP | pX, Alix | ESCRT subunits | C-terminal of Px interacts with V domain of Alix to sort the eGFPpX into exosomes. | Promotes secretion of virions and foreign proteins through exosomes. | 1 | [33] | |
AQP2 | LIP5, Vps4 | LIP5 binds with AQP2, and CHMP1B recruit LIP5 to MVBs, which then fuse with plasma membrane to release as exosomes. | Transfer specific membrane proteins so as to respond to cellular and environmental signals. | / | [36] | ||
β-catenin | Vps4A, CHMP4B | Vps4A may facilitate the sorting of β-catenin into exosomes through the interaction with β-catenin and CHMP4B. | Prevent epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma by dampening β-catenin signing | 1 and 5 | [37] | ||
Stomatin flottlin-1 |
lipid rafts | lipid and tetraspanins | Lipoproteins associated with lipid raft components | Emphasizing the existence of lipidmicrodomains in exosomal membranes and the direct impact of exosomes in regulatory mechanisms | 1 and 2 | [40,41] | |
LMP1 | CD63 | Copurification of CD63 for its completed location patterns | LMP1-modified exosomes show the ability to enhance progression of EBV-associated cancers. | 1 and 2 | [46] | ||
CD10 | CD9 | CD9 interacts with CD10 via establishing the chimeras | Release of CD10 peptidase activity with exosomes may effectively regulate extracellular matrix microenvironments |
1 | [48] | ||
RNA | miR-198, miR-601 | hnRNPA2B1 | RNA Binding Proteins | SUMOylation of hnRNPA2B1 bind with GGAG of some miRNAs. | GGAG motif | 1 and 2 | [61] |
miR-3470a, miR-194 | SYNCRIP | RBPs bind with motifs of specific miRNAs | GGCU motif | 1 | [65] | ||
miR-233, miR-133 | YBX-1 | CAUC motif | 1 and 2 and 3 | [66,67,69] | |||
miR-193 | MVP | NA | 1 and 2 | [71] | |||
miR-155 | FMR1 | AAUGC motif | 1 | [77] | |||
miR-10b, let-7a | Ago2 | Ago2 bind with miRNA to form an Ago2-miRNA complex | NA | 1 and 2 | [79–86] | ||
miR-10b, miR-100 | KRAS, | KRAS status and nSMase2 influence the profile and the level of miRNA. | Change of miRNA expression may play therapeutic roles in reversing the tumorigenic effects on account of the aberrant miRNA expression. | 1 | [86] | ||
miR-210 miR-10b |
nSMase2 | Release of exosomes and exosomal miRNA are regulated by nSMase2. | [84, 85] | ||||
mRNA | CTGCC core domain, miRNA-binding site | Zipcode-like 25 nucleotide sequence which contain CTGCC core domain and miRNA-binding site work as a Zipcode exist in the 3’UTR of mRNA to promote the sorting. | Can be a potential approach for cancer gene therapy by incorporating sequences into 3’UTR of therapeutic RNAs. |
1 | [89] | ||
YB-1 | RNA Binding Proteins | YB-1 recognize and bind to eRNA-specific motifs with different affinity, and this connection is assisted by the C-terminal of YB-1. | (1) ACCAGCCU (2) UAAUCCCA (3) CAGUGAGC |
1 | [90] | ||
DNA | gDNA | Micronuclei (MN), Tetraspanins | CD63 surrounded gDNA released by disrupted MN, and participate in the exosome biogenesis and finally be sorted into exosomes. | Highlights the function of nEXO in cancer biomarker development. | 1 and 4 | [94] |